NDRG2, a tumor suppressor gene, has been shown to inhibit the growth and metastasis of many malignant tumors, including HCC, and its expression level is positively associated with the prognosis and survival outcomes of cancer patients [56–58]. This evidence concerns the gene NDRG2 and hepatocellular carcinoma.